Aakaar Medical Technologies (NSE:AAKAAR) Total Long-Term Assets: ₹28.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AAKAAR Aakaar Medical Technologies Ltd NSE:AAKAAR
21 GF Score
Price ₹58.40
! 3 Warning Signs
View Full Analysis

What is Aakaar Medical Technologies Total Long-Term Assets?

Aakaar Medical Technologies NSE:AAKAAR +4.90% 21 Total Long-Term Assets is ₹28.0 Mil as of Mar. 2026. GuruFocus rates NSE:AAKAAR with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Aakaar Medical Technologies's Total Long-Term Assets for the quarter that ended in Mar. 2026 was ₹28.0 Mil.

Aakaar Medical Technologies Total Long-Term Assets Related Terms

Aakaar Medical Technologies Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Aakaar Medical Technologies's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aakaar Medical Technologies Total Long-Term Assets Chart

Aakaar Medical Technologies Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Long-Term Assets
6.68 10.07 12.01 23.24 28.05

Aakaar Medical Technologies Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Long-Term Assets Get a 7-Day Free Trial 12.01 0.00 23.24 192.72 28.05
NSE:AAKAAR
21GF Score
Aakaar Medical Technologies Ltd NSE:AAKAAR
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aakaar Medical Technologies Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of ₹28.0 Mil mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Total Long-Term Assets of ₹28.0 Mil as of Mar. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Aakaar Medical Technologies and its competitors.
Is Aakaar Medical Technologies' Total Long-Term Assets too high?
Aakaar Medical Technologies' current Total Long-Term Assets is ₹28.0 Mil. Overall, Aakaar Medical Technologies has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Total Long-Term Assets compare to ABT and SYK?
Aakaar Medical Technologies' Total Long-Term Assets of ₹28.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Aakaar Medical Technologies and its competitors. Aakaar Medical Technologies's current Total Long-Term Assets is ₹28.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Total Long-Term Assets of ₹28.0 Mil. The current Total Long-Term Assets is ₹28.0 Mil. Aakaar Medical Technologies' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Total Long-Term Assets is ₹28.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aakaar Medical Technologies Business Description

Address Telli Galli Cross Road, A - 801, Heritage Plaza, Andheri East, Mumbai, MH, IND, 400 069
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
21GF Score

Get the complete analysis for NSE:AAKAAR

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹58.40
Price